You are here

gout

Savient Pharma: Cheap Biotech Without FDA Approval Risk

Seeking Alpha

Tue, 04/26/11 - 06:18 am

BioCryst to Present New BCX4208 Gout Results at the Annual European Congress of Rheumatology

Yahoo/BusinessWire

Sat, 04/23/11 - 10:46 am

purine nucleoside phosphorylase inhibitor

Gout medicine Colcrys' pricing under scrutiny

Fierce Pharma

Tue, 03/29/11 - 11:44 am

Regeneron Announces Strong Results In Gout Study

Forbes

Mon, 02/28/11 - 12:26 pm

Savient Reports Batch Failures With New Gout Medicine

Bloomberg

Fri, 01/7/11 - 10:34 am

Savient: Risky but Promising Small Cap

Seeking Alpha

Sun, 10/31/10 - 10:58 am

NJ's Savient plans to handle launch of new gout drug on its own

Newark Star-Ledger, NJ

Thu, 10/28/10 - 08:11 am

Savient Investors Expect a Sale

TheStreet.com

Wed, 09/15/10 - 08:06 am

Bristol-Myers Squibb

Savient Pharmaceuticals' Krystexxa Approved for Gout

Bloomberg

Wed, 09/15/10 - 07:35 am

Savient: Drug Approval or Another Delay?

TheStreet.com

Fri, 09/10/10 - 11:15 am

A Reintroduction to Savient's Krystexxa

Seeking Alpha

Thu, 08/12/10 - 11:28 am

New Data from Five Clinical Studies Reinforce RDEA594's Robust Efficacy and Encouraging Safety Profile

PipeLine Review

Sat, 06/19/10 - 12:38 pm

The Drug Passed, but the Stock Fell?

Motley Fool

Thu, 06/10/10 - 09:22 am

BioCryst rallies on gout study; AMAG shares fall

Marketwatch

Wed, 04/28/10 - 11:33 am

Amag Pharmaceuticals

Ardea's Gout Drug Progresses

Seeking Alpha

Fri, 04/2/10 - 09:14 am

Ardea Presents Gout Data

Yahoo/Zacks

Sat, 10/24/09 - 10:51 am

Savient Pharma recovers after analyst upgrade

Yahoo/AP

Sat, 10/10/09 - 12:39 pm

Savient sticks to Krystexxa resubmission target

Marketwatch

Wed, 09/16/09 - 09:13 am

Analyst says Savient Pharma could be bought out after meeting with FDA over gout drug

Yahoo/AP

Thu, 09/3/09 - 02:05 pm

FDA Rejection Could Damage Savient's Credibility

Forbes

Mon, 08/3/09 - 10:46 am

Pages